Do you use docetaxel interchangeably with paclitaxel in breast cancer?
Does the answer vary based on whether it is neo/adjuvant or metastatic setting?
Community PollStarted
What do you consider a reasonable taxane choice in the (neo)adjuvant setting?
134 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Mayo Clinic Rochester
Answered on
The nuanced answer would be attuned to receptors, disease status (e.g. non-metastatic vs metastatic) and schedule.
In the adjuvant setting, defining studies include E1199 (Sparano et al JCO 2015) and S0221(Budd et al JCO 2015).
- The ECOG trial examined weekly paclitaxel vs weekly docetaxel vs q3wk pac...
Join for free or sign in to see the full answer